1 – 10 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
- Contribution to journal › Article
- 2023
-
Mark
Mitigation of pretreatment-derived inhibitors during lignocellulosic ethanol fermentation using spent grain as a nitrogen source
- Contribution to journal › Article
-
Mark
Physiological and Molecular Characterization of Yeast Cultures Pre-Adapted for Fermentation of Lignocellulosic Hydrolysate
- Contribution to journal › Article
-
Mark
Optimization of N-Piperidinyl-Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8-Oxo-Guanine DNA Glycosylase 1
- Contribution to journal › Article
-
Mark
P90 ribosomal S6 kinases : A bona fide target for novel targeted anticancer therapies?
- Contribution to journal › Scientific review
-
Mark
Dilemmas on emicizumab in children with haemophilia A : A survey of strategies from PedNet centres
- Contribution to journal › Article
-
Mark
Haemophilia B - Diagnostic Insights, Genetic Aspects and Clinical Outcomes
(2023) In Lund University, Faculty of Medicine, Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Pharmacoepigenetics in type 2 diabetes : is it clinically relevant?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
- Contribution to journal › Article
-
Mark
New Inhibitors in the Ageing Population : A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia
- Contribution to journal › Article
